Botulinum toxin - Daewoong PharmaceuticalsAlternative Names: Nabota 7S; Nabota Next
Latest Information Update: 06 Mar 2014
At a glance
- Originator Daewoong Pharmaceutical
- Class Antispasmodics; Bacterial proteins; Bacterial toxins; Muscle relaxants
- Mechanism of Action Acetylcholine inhibitors; Glutamate-antagonists; Neuromuscular blocking agents
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Glabellar lines
Most Recent Events
- 06 Mar 2014 Early research in Glabellar lines in South Korea (Parenteral)